Clinical trial NCT00695357: Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
Official title: Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: New Strategies
GINA 2006
Patient Opinion
Keywords: Asthma treatment
GINA 2006
patient perception
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2008-06-11
Enrollment: 832
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Primary care

Brief summary: Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.


Eligibility criteria: Inclusion Criteria:

* Patients diagnosed with persistent asthma (GINA 2005) for at least 6 months before entering the study
* Patients who are under treatment according to the new strategies described in GINA 2006 for at least 3 months before entering the study

Exclusion Criteria:

* Patients who are not willing to sign the Informed Consent Form
* COPD Patients

Primary outcomes:
measure: Percentage (%) of Asthma treatment satisfaction and control grading
timeFrame: single visit / once
Secondary outcomes:
measure: Rate of treatment compliance
timeFrame: single visit / once
measure: Patients quality of life under treatment
timeFrame: single visit / once
Other outcomes:
Locations:
city: Aleksandroupoli
country: Greece
facility: Research Site
city: Amaliada
country: Greece
facility: Research Site
city: Argos
country: Greece
facility: Research Site
city: Arta
country: Greece
facility: Research Site
city: Athina
country: Greece
facility: Research Site
city: Chania
country: Greece
facility: Research Site
city: Drama
country: Greece
facility: Research Site
city: Githio
country: Greece
facility: Research Site
city: Gounari
country: Greece
facility: Research Site
city: Imathia
country: Greece
facility: Research Site
city: Ioannina
country: Greece
facility: Research Site
city: Iraklio
country: Greece
facility: Research Site
city: Kalamata
country: Greece
facility: Research Site
city: Katerini
country: Greece
facility: Research Site
city: Kavala
country: Greece
facility: Research Site
city: Komotini
country: Greece
facility: Research Site
city: Lamia
country: Greece
facility: Research Site
city: Larisa
country: Greece
facility: Research Site
city: Nafpaktos
country: Greece
facility: Research Site
city: Neapoli
country: Greece
facility: Research Site
city: Patra
country: Greece
facility: Research Site
city: Pirgos
country: Greece
facility: Research Site
city: Rafina
country: Greece
facility: Research Site
city: Serres
country: Greece
facility: Research Site
city: Sparti
country: Greece
facility: Research Site
city: Thessaloniki
country: Greece
facility: Research Site
city: Trikala
country: Greece
facility: Research Site
city: Tripoli
country: Greece
facility: Research Site
city: Veria
country: Greece
facility: Research Site
city: Volos
country: Greece
facility: Research Site
city: Xalkida
country: Greece
facility: Research Site
Study officials:
affiliation: Euroclinic, Athens, Greece
name: Zachariadis Manolis, MD
role: PRINCIPAL_INVESTIGATOR
References: